Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
147.33
+0.06 (0.04%)
May 9, 2025, 10:34 AM - Market open
Cardinal Health Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 143.8, with a low estimate of 120 and a high estimate of 170. The average target predicts a decrease of -2.40% from the current stock price of 147.33.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 6 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $142 → $166 | Buy | Maintains | $142 → $166 | +12.67% | May 5, 2025 |
| UBS | UBS | Strong Buy Maintains $160 → $170 | Strong Buy | Maintains | $160 → $170 | +15.39% | May 2, 2025 |
| Baird | Baird | Buy Maintains $156 → $170 | Buy | Maintains | $156 → $170 | +15.39% | May 2, 2025 |
| UBS | UBS | Strong Buy Maintains $150 → $160 | Strong Buy | Maintains | $150 → $160 | +8.60% | Apr 29, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $150 → $155 | Strong Buy | Maintains | $150 → $155 | +5.21% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
225.35B
from 226.83B
Decreased by -0.65%
Revenue Next Year
245.09B
from 225.35B
Increased by 8.76%
EPS This Year
8.04
from 3.45
Increased by 132.90%
EPS Next Year
9.06
from 8.04
Increased by 12.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 236.1B | 264.6B | 285.6B | ||
| Avg | 225.3B | 245.1B | 263.2B | ||
| Low | 215.5B | 233.5B | 246.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1% | 17.4% | 16.5% | ||
| Avg | -0.7% | 8.8% | 7.4% | ||
| Low | -5.0% | 3.6% | 0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.41 | 9.63 | 10.83 | ||
| Avg | 8.04 | 9.06 | 10.04 | ||
| Low | 7.75 | 8.57 | 9.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 143.8% | 19.8% | 19.5% | ||
| Avg | 132.9% | 12.7% | 10.9% | ||
| Low | 124.7% | 6.6% | 4.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.